Merck | MRK - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Adidas EUR 2.98B 300M 2026-06
Adyen EUR 90.22M 65.93M 2026-06
Akzo Nobel EUR 833M 29M 2026-06
Alcon AG USD 964M 82M 2026-06
Amadeus IT EUR 497.5M 206.6M 2025-03
Amarin USD 18.97M 1.03M 2025-12
AstraZeneca USD 5.8B 735M 2026-06
BASF EUR 2.28B 156M 2026-06
Bayer EUR 3.96B 267M 2026-06
Beiersdorf EUR 271M 51M 2025-12
Covestro EUR 445M 8M 2025-12
Danone EUR 3.14B 1.56B 2026-06
Fresenius EUR 760M 17M 2026-06
Fresenius Medical Care EUR 736.01M 12.99M 2026-06
Genmab DKK 205M 39M 2026-06
Givaudan CHF 561M 25M 2025-12
GlaxoSmithKline GBP 2.19B 75M 2026-06
GRIFOLS EUR 289M 8M 2026-06
Henkel EUR 3.5B 13M 2026-06
Hikma Pharmaceutical USD 288M 149M 2025-12
Infineon EUR 433M 54M 2026-06
Lakefront Biotherapeutics EUR 22.5M 13M 2026-06
Linde USD 893M 13M 2026-03
Merck EUR 1.57B 49M 2026-06
Novartis USD 3.24B 101M 2026-06
Philips EUR 1.21B 23M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.63B 307M 2026-06
UCB EUR 1.47B 193M 2025-12